Breast Cancer Risk and Genetic Testing
New class of drugs: poly (ADP-ribose) polymerase, or PARP inhibitors
BSI-201 (one of the new class of drug), in combination with conventional chemotherapy, significantly improved overall and progression-free survival in women with metastatic triple-negative breast cancer, compared with chemotherapy alone.
Source: MD Anderson’s Department of Breast Medical Oncology’s report
3D Mamography advances Breast Cancer Detection
3D Mamograohy offers enhanced image quality and the ability to view through and around dense breast tissue. It reveals the inner structures of the breast tissue, by layers and from various angles and can reveal hiddden tumors especially in women who have dense breast tissue. Women who previous mamograms have demonstrated dense breast tissue may especially benefit from 3D mamography. Source : Texas Health Presbyterian Hospital Plano’s